📂 Drugs
AZD2693 — Definition
AZD2693 / AZD2693
AZD2693 is an experimental antisens oligonucleotitis drug candidate, which is developed for the treatment of steatohepatit (MASH) associated with metabolic dysfunction, characterized by excessive fat accumulation and inflammation in the liver. This drug aims to reduce fat accumulation in liver cells by targeting abnormal lipid metabolism caused by pathological variant (I148M). In clinical pre-clinical and early phase clinical studies, AZD2693 has always reduced the levels of the hepatic triglycerides and slowing the progress of fibrosis. Not yet licensed and advanced phase studies continue to verify safety and activity data.
Frequently Asked Questions
❓ What is AZD2693?
AZD2693; aZD2693 is an experimental antisens oligonucleotitis drug candidate, which is developed for the treatment of steatohepatit (MASH) associated with metabolic dysfunction, characterized by excessive fat accumulation and inflammation in the liver. This drug aims to reduce fat accumulation in liver cells by targeting abnormal lipid metabolism caused by pathological variant (I148M). In clinical pre-clinical and early phase clinical studies, AZD2693 has always reduced the levels of the hepatic triglycerides and slowing the progress of fibrosis. Not yet licensed and advanced phase studies continue to verify safety and activity data.
❓ What is AZD2693 in Turkish?
The Turkish equivalent of "AZD2693" is AZD2693.
❓ Which medical field is AZD2693 related to?
This term belongs to the Drugs category.